SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5wna'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T7I_A_017A200_2 (POL POLYPROTEIN)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	ASP H 62 VAL H 64 GLY H 50 ILE H 51	None	0.76A	1t7iB-5wnaH: undetectable	1t7iB-5wnaH: 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TKQ_B_DVAB8_0 (GRAMICIDIN A)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	4 / 5	VAL H 23 GLY H 24 VAL H 5 TRP H 114	None	1.28A	1tkqB-5wnaH: undetectable	1tkqB-5wnaH: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WOP_A_FFOA2887_1 (AMINOMETHYLTRANSFERA SE)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	3 / 3	ASP H 112 GLU H 6 ARG H 72	None	0.80A	1wopA-5wnaH: 2.0	1wopA-5wnaH: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NU9_A_478A401_1 (PROTEASE)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	4 / 8	ASP H 62 VAL H 64 GLY H 50 ILE H 51	None	0.77A	3nu9A-5wnaH: undetectable	3nu9A-5wnaH: 21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A81_A_DXCA1161_0 (MAJOR POLLEN ALLERGEN BET V 1-A)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	GLY H 24 ILE H 98 VAL H 100 ASN H 54 LEU H 79	None	1.21A	4a81A-5wnaH: undetectable	4a81A-5wnaH: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.84A	4qvnH-5wnaH: undetectable 4qvnI-5wnaH: undetectable	4qvnH-5wnaH: 18.50 4qvnI-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 10	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.84A	4qvnV-5wnaH: undetectable 4qvnW-5wnaH: undetectable	4qvnV-5wnaH: 18.50 4qvnW-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.82A	4qvpH-5wnaH: undetectable 4qvpI-5wnaH: undetectable	4qvpH-5wnaH: 18.50 4qvpI-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.82A	4qvpV-5wnaH: undetectable 4qvpW-5wnaH: undetectable	4qvpV-5wnaH: 18.50 4qvpW-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.83A	4qvqH-5wnaH: undetectable 4qvqI-5wnaH: undetectable	4qvqH-5wnaH: 18.50 4qvqI-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.82A	4qvqV-5wnaH: undetectable 4qvqW-5wnaH: undetectable	4qvqV-5wnaH: 18.50 4qvqW-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.86A	4qvvH-5wnaH: undetectable	4qvvH-5wnaH: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.86A	4qvvV-5wnaH: undetectable	4qvvV-5wnaH: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.84A	4qvyH-5wnaH: undetectable	4qvyH-5wnaH: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.84A	4qvyV-5wnaH: undetectable 4qvyW-5wnaH: undetectable	4qvyV-5wnaH: 18.50 4qvyW-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.84A	4qw0H-5wnaH: undetectable 4qw0I-5wnaH: undetectable	4qw0H-5wnaH: 18.50 4qw0I-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.84A	4qw0V-5wnaH: undetectable 4qw0W-5wnaH: undetectable	4qw0V-5wnaH: 18.50 4qw0W-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.85A	4qw1H-5wnaH: undetectable 4qw1I-5wnaH: undetectable	4qw1H-5wnaH: 18.50 4qw1I-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.85A	4qw1V-5wnaH: undetectable 4qw1W-5wnaH: undetectable	4qw1V-5wnaH: 18.50 4qw1W-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.85A	4qwuH-5wnaH: undetectable 4qwuI-5wnaH: undetectable	4qwuH-5wnaH: 18.50 4qwuI-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.85A	4qwuV-5wnaH: undetectable 4qwuW-5wnaH: undetectable	4qwuV-5wnaH: 18.50 4qwuW-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R3A_B_RBFB402_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5wna	MAB 3D3 FAB HEAVY CHAIN MAJOR SURFACE GLYCOPROTEIN G (Homo sapiens; Human orthopneumovirus)	5 / 10	ILE B 189 GLU H 30 ASN H 74 LEU H 79 LEU H 27	None	1.26A	4r3aB-5wnaB: undetectable	4r3aB-5wnaB: 5.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.83A	5bxnH-5wnaH: undetectable 5bxnI-5wnaH: undetectable	5bxnH-5wnaH: 16.37 5bxnI-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.84A	5cz7V-5wnaH: undetectable 5cz7W-5wnaH: undetectable	5cz7V-5wnaH: 18.50 5cz7W-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.83A	5d0xV-5wnaH: undetectable	5d0xV-5wnaH: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.80A	5l5fH-5wnaH: undetectable 5l5fI-5wnaH: undetectable	5l5fH-5wnaH: 18.50 5l5fI-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.81A	5l5fV-5wnaH: undetectable 5l5fW-5wnaH: undetectable	5l5fV-5wnaH: 18.50 5l5fW-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.85A	5l66H-5wnaH: undetectable 5l66I-5wnaH: undetectable	5l66H-5wnaH: 18.50 5l66I-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.84A	5l66V-5wnaH: undetectable 5l66W-5wnaH: undetectable	5l66V-5wnaH: 18.50 5l66W-5wnaH: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF0_A_SAMA505_0 (CARNOSINE N-METHYLTRANSFERASE)	5wna	MAJOR SURFACE GLYCOPROTEIN G MAB 3D3 FAB HEAVY CHAIN (Human orthopneumovirus ; Homo sapiens)	5 / 12	GLY H 59 GLY H 50 ASN B 161 SER H 55 PHE H 68	None	1.35A	5yf0A-5wnaH: undetectable	5yf0A-5wnaH: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_H_BO2H301_0 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.92A	6hwdH-5wnaH: undetectable 6hwdI-5wnaH: undetectable	6hwdH-5wnaH: 19.54 6hwdI-5wnaH: 23.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_V_BO2V301_0 (PROTEASOME SUBUNIT BETA TYPE-2)	5wna	MAB 3D3 FAB HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 199 GLY H 145 THR H 146 ALA H 147 THR H 142	None	0.92A	6hwdV-5wnaH: undetectable	6hwdV-5wnaH: 19.54

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1T7I_A_017A200_2","POL POLYPROTEIN;POL POLYPROTEIN","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",4,"ASP H  62;VAL H  64;GLY H  50;ILE H  51","None","0.76A","1t7iB-5wnaH:undetectable","1t7iB-5wnaH:20.75"],["1TKQ_B_DVAB8_0","GRAMICIDIN A","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",4,"VAL H  23;GLY H  24;VAL H   5;TRP H 114","None","1.28A","1tkqB-5wnaH:undetectable","1tkqB-5wnaH:undetectable"],["1WOP_A_FFOA2887_1","AMINOMETHYLTRANSFERASE","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",3,"ASP H 112;GLU H   6;ARG H  72","None","0.80A","1wopA-5wnaH:2.0","1wopA-5wnaH:undetectable"],["3NU9_A_478A401_1","PROTEASE","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",4,"ASP H  62;VAL H  64;GLY H  50;ILE H  51","None","0.77A","3nu9A-5wnaH:undetectable","3nu9A-5wnaH:21.70"],["4A81_A_DXCA1161_0","MAJOR POLLEN ALLERGEN BET V 1-A","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"GLY H  24;ILE H  98;VAL H 100;ASN H  54;LEU H  79","None","1.21A","4a81A-5wnaH:undetectable","4a81A-5wnaH:undetectable"],["4QVN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.84A","4qvnH-5wnaH:undetectable;4qvnI-5wnaH:undetectable","4qvnH-5wnaH:18.50;4qvnI-5wnaH:21.48"],["4QVN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.84A","4qvnV-5wnaH:undetectable;4qvnW-5wnaH:undetectable","4qvnV-5wnaH:18.50;4qvnW-5wnaH:21.48"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.82A","4qvpH-5wnaH:undetectable;4qvpI-5wnaH:undetectable","4qvpH-5wnaH:18.50;4qvpI-5wnaH:21.48"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.82A","4qvpV-5wnaH:undetectable;4qvpW-5wnaH:undetectable","4qvpV-5wnaH:18.50;4qvpW-5wnaH:21.48"],["4QVQ_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.83A","4qvqH-5wnaH:undetectable;4qvqI-5wnaH:undetectable","4qvqH-5wnaH:18.50;4qvqI-5wnaH:21.48"],["4QVQ_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.82A","4qvqV-5wnaH:undetectable;4qvqW-5wnaH:undetectable","4qvqV-5wnaH:18.50;4qvqW-5wnaH:21.48"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.86A","4qvvH-5wnaH:undetectable","4qvvH-5wnaH:18.50"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.86A","4qvvV-5wnaH:undetectable","4qvvV-5wnaH:18.50"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.84A","4qvyH-5wnaH:undetectable","4qvyH-5wnaH:18.50"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.84A","4qvyV-5wnaH:undetectable;4qvyW-5wnaH:undetectable","4qvyV-5wnaH:18.50;4qvyW-5wnaH:21.48"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.84A","4qw0H-5wnaH:undetectable;4qw0I-5wnaH:undetectable","4qw0H-5wnaH:18.50;4qw0I-5wnaH:21.48"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.84A","4qw0V-5wnaH:undetectable;4qw0W-5wnaH:undetectable","4qw0V-5wnaH:18.50;4qw0W-5wnaH:21.48"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.85A","4qw1H-5wnaH:undetectable;4qw1I-5wnaH:undetectable","4qw1H-5wnaH:18.50;4qw1I-5wnaH:21.48"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.85A","4qw1V-5wnaH:undetectable;4qw1W-5wnaH:undetectable","4qw1V-5wnaH:18.50;4qw1W-5wnaH:21.48"],["4QWU_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.85A","4qwuH-5wnaH:undetectable;4qwuI-5wnaH:undetectable","4qwuH-5wnaH:18.50;4qwuI-5wnaH:21.48"],["4QWU_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.85A","4qwuV-5wnaH:undetectable;4qwuW-5wnaH:undetectable","4qwuV-5wnaH:18.50;4qwuW-5wnaH:21.48"],["4R3A_B_RBFB402_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5wna","MAB 3D3 FAB HEAVY CHAIN;MAJOR SURFACE GLYCOPROTEIN G","Homo sapiens;Human orthopneumovirus",5,"ILE B 189;GLU H  30;ASN H  74;LEU H  79;LEU H  27","None","1.26A","4r3aB-5wnaB:undetectable","4r3aB-5wnaB:5.85"],["5BXN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.83A","5bxnH-5wnaH:undetectable;5bxnI-5wnaH:undetectable","5bxnH-5wnaH:16.37;5bxnI-5wnaH:21.48"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.84A","5cz7V-5wnaH:undetectable;5cz7W-5wnaH:undetectable","5cz7V-5wnaH:18.50;5cz7W-5wnaH:21.48"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.83A","5d0xV-5wnaH:undetectable","5d0xV-5wnaH:18.50"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.80A","5l5fH-5wnaH:undetectable;5l5fI-5wnaH:undetectable","5l5fH-5wnaH:18.50;5l5fI-5wnaH:21.48"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.81A","5l5fV-5wnaH:undetectable;5l5fW-5wnaH:undetectable","5l5fV-5wnaH:18.50;5l5fW-5wnaH:21.48"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.85A","5l66H-5wnaH:undetectable;5l66I-5wnaH:undetectable","5l66H-5wnaH:18.50;5l66I-5wnaH:21.48"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.84A","5l66V-5wnaH:undetectable;5l66W-5wnaH:undetectable","5l66V-5wnaH:18.50;5l66W-5wnaH:21.48"],["5YF0_A_SAMA505_0","CARNOSINE N-METHYLTRANSFERASE","5wna","MAJOR SURFACE GLYCOPROTEIN G;MAB 3D3 FAB HEAVY CHAIN","Human orthopneumovirus;Homo sapiens",5,"GLY H  59;GLY H  50;ASN B 161;SER H  55;PHE H  68","None","1.35A","5yf0A-5wnaH:undetectable","5yf0A-5wnaH:undetectable"],["6HWD_H_BO2H301_0","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.92A","6hwdH-5wnaH:undetectable;6hwdI-5wnaH:undetectable","6hwdH-5wnaH:19.54;6hwdI-5wnaH:23.71"],["6HWD_V_BO2V301_0","PROTEASOME SUBUNIT BETA TYPE-2","5wna","MAB 3D3 FAB HEAVY CHAIN","Homo sapiens",5,"SER H 199;GLY H 145;THR H 146;ALA H 147;THR H 142","None","0.92A","6hwdV-5wnaH:undetectable","6hwdV-5wnaH:19.54"]]